VA

Verdad Advisers Portfolio holdings

AUM $88.8M
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
–
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$88.8M
AUM Growth
+$1.45M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
237
New
Increased
Reduced
Closed

Top Buys

1
+$2.49M
2
+$2.32M
3
+$2.18M
4
STT icon
State Street
STT
+$2.13M
5
ZYME icon
Zymeworks
ZYME
+$1.96M

Top Sells

1
+$4.03M
2
+$3.81M
3
+$2.79M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$2.66M
5
CVX icon
Chevron
CVX
+$2.55M

Sector Composition

1 Healthcare 41.87%
2 Technology 13.22%
3 Financials 10.56%
4 Consumer Discretionary 7.94%
5 Communication Services 7.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BLTE
1
Belite Bio
BLTE
$5.43B
$2.2M 2.48%
+13,813
STT icon
2
State Street
STT
$44.2B
$2.11M 2.37%
+16,665
ATHM icon
3
Autohome
ATHM
$2.11B
$2.11M 2.37%
+121,317
RVMD icon
4
Revolution Medicines
RVMD
$32.2B
$2.1M 2.36%
+21,572
ZYME icon
5
Zymeworks
ZYME
$1.77B
$2.07M 2.33%
+82,698
CALM icon
6
Cal-Maine
CALM
$3.53B
$1.95M 2.2%
24,637
+3,986
ZM icon
7
Zoom
ZM
$32.8B
$1.73M 1.95%
21,580
+649
CRC icon
8
California Resources
CRC
$5.48B
$1.56M 1.75%
22,500
+15,320
TENX icon
9
Tenax Therapeutics
TENX
$291M
$1.52M 1.72%
+95,330
ACAD icon
10
Acadia Pharmaceuticals
ACAD
$3.58B
$1.52M 1.71%
+68,290
PARR icon
11
Par Pacific Holdings
PARR
$2.87B
$1.41M 1.59%
+22,500
JNJ icon
12
Johnson & Johnson
JNJ
$537B
$1.32M 1.49%
5,418
-11,990
MU icon
13
Micron Technology
MU
$1.2T
$1.3M 1.46%
3,841
-2,945
NRIX icon
14
Nurix Therapeutics
NRIX
$1.69B
$1.29M 1.46%
+83,425
CMCSA icon
15
Comcast
CMCSA
$88.7B
$1.19M 1.34%
41,549
-56,847
AHCO icon
16
AdaptHealth
AHCO
$1.31B
$1.13M 1.27%
+95,000
CTNM
17
Contineum Therapeutics
CTNM
$465M
$1.12M 1.26%
+86,032
LRCX icon
18
Lam Research
LRCX
$418B
$1.1M 1.24%
5,163
-10,308
CLDT
19
Chatham Lodging
CLDT
$516M
$1.1M 1.24%
140,000
+25,000
BNY
20
Bank of New York Mellon
BNY
$97.2B
$1.06M 1.2%
8,951
-5,810
AXSM icon
21
Axsome Therapeutics
AXSM
$11.4B
$1.01M 1.14%
+5,971
CLYM
22
Climb Bio
CLYM
$642M
$990K 1.11%
+144,540
AMAT icon
23
Applied Materials
AMAT
$389B
$989K 1.11%
+2,894
DSGN icon
24
Design Therapeutics
DSGN
$633M
$982K 1.11%
+92,310
JLL icon
25
Jones Lang LaSalle
JLL
$13.7B
$963K 1.08%
3,163
+2,473
1
2 3 4 5